Clinical Trial Update: Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform [NA]

View source ↗

Summary

Clinical trial update shows Signos Inc is evaluating continuous glucose monitoring in a non-diabetic population to complement the Signos Mobile Health Platform,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Intolerance
• Glucose Metabolism Disorders
• Metabolic Syndrome
• Obesity
• Prediabetes

Snippet

Sponsor: Signos Inc | Conditions: Weight Loss, Metabolic Syndrome | NA | Status: ACTIVE_NOT_RECRUITING